Pinnacle Bancorp, Inc. Amgen Inc Transaction History

Pinnacle Bancorp, Inc.

$370 Million
Q3 2024

A detailed history of Pinnacle Bancorp, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Pinnacle Bancorp, Inc. holds 532 shares of AMGN stock, worth $156,689. This represents 0.05% of its overall portfolio holdings.

Number of Shares

532

Previous 584 8.9%

Holding current value

$156,689

Previous $182,000 6.04%

% of portfolio

0.05%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$309.38 - $337.38 $16,087 - $17,543	-52 Reduced 8.9%	532 $171,000
Q2 2024 Jul 15, 2024	BUY	$262.75 - $319.31 $23,910 - $29,057	91 Added 18.46%	584 $182,000
Q1 2024 Apr 16, 2024	BUY	$268.87 - $324.56 $12,905 - $15,578	48 Added 10.79%	493 $140,000
Q3 2023 Oct 18, 2023	BUY	$218.65 - $271.46 $5,466 - $6,786	25 Added 5.95%	445 $119,000
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $5,356 - $6,334	-25 Reduced 5.62%	420 $93,000
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $2,748 - $3,492	-12 Reduced 2.63%	445 $117,000
Q2 2022 Jul 12, 2022	SELL	$230.71 - $256.74 $3,460 - $3,851	-15 Reduced 3.18%	457 $111,000
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $5,701 - $6,306	26 Added 5.83%	472 $114,000
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $14,717 - $16,842	74 Added 19.89%	446 $100,000
Q2 2021 Jul 15, 2021	BUY	$233.58 - $259.14 $3,503 - $3,887	15 Added 4.2%	372 $91,000
Q4 2020 Jan 13, 2021	BUY	$216.38 - $257.67 $2,163 - $2,576	10 Added 2.88%	357 $82,000
Q3 2020 Oct 13, 2020	BUY	$234.65 - $260.95 $5,866 - $6,523	25 Added 7.76%	347 $88,000
Q1 2020 Apr 09, 2020	SELL	$182.24 - $241.7 $5,284 - $7,009	-29 Reduced 8.26%	322 $65,000
Q4 2019 Jan 10, 2020	BUY	$189.21 - $243.2 $5,487 - $7,052	29 Added 9.01%	351 $85,000
Q4 2018 Mar 20, 2019	BUY	$178.4 - $208.25 $57,444 - $67,056	322 New	322 $63,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.

Account

Pinnacle Bancorp, Inc. Amgen Inc Transaction History